Abbott Laboratories (ETR:ABL)
111.72
+1.26 (1.14%)
Aug 15, 2025, 5:35 PM CET
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of €195.83 billion as of August 15, 2025. Its market cap has increased by 14.98% in one year.
Market Cap
195.83B
Enterprise Value
201.34B
Revenue
36.71B
Ranking
n/a
PE Ratio
16.51
Stock Price
€111.72
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 195.83B, an increase of 30,676.77%. That is a compound annual growth rate of 10.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 195.83B | 3.34% |
Dec 31, 2024 | 189.49B | 9.61% |
Dec 29, 2023 | 172.88B | -3.48% |
Dec 30, 2022 | 179.12B | -15.60% |
Dec 31, 2021 | 212.23B | 38.39% |
Dec 31, 2020 | 153.36B | 12.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Siemens Healthineers AG | 51.79B |
Merck KGaA | 48.28B |
Bayer Aktiengesellschaft | 26.33B |
Fresenius SE & Co. KGaA | 25.67B |
Fresenius Medical Care AG | 12.48B |
Sartorius Aktiengesellschaft | 12.38B |
Fielmann Group AG | 4.64B |
Carl Zeiss Meditec AG | 3.77B |